Pharmacotherapy and immunotherapy of allergic rhinitis induced by house dust mite, grass, and birch pollen allergens: a meta-analysis of randomized clinical trials

References

• Meltzer EO. Allergic rhinitis. Burden of illness, quality of life, comorbidities, and control. Immunol Allergy Clin North Am. 2016;36:235–248. doi: 10.1016/j.iac.2015.12.002
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lan F, Zhang L. Advances and highlights in allergic rhinitis. Allergy: Eur J Allergy Clin Immunol. 2021;76(11):3383–3389. doi: 10.1111/all.15044
   Google Scholar
• Schuler IC, Montejo JM. Allergic rhinitis in children and adolescents. Pediatr Clin North Am. 2019;66(5):981–993. doi: 10.1016/j.pcl.2019.06.004
   PubMed Web of Science ®Google Scholar
• Bernstein DI, Schwartz G, Bernstein JA. Allergic rhinitis: Mechanisms and Treatment. Immunol Allergy Clin North Am. 2016;36:261–278. doi: 10.1016/j.iac.2015.12.004
   PubMed Web of Science ®Google Scholar
• Kakli HA, Riley TD. Allergic Rhinitis. Prim Care - Clin Off Pract. 2016;43:465–475. doi: 10.1016/j.pop.2016.04.009
   PubMed Web of Science ®Google Scholar
• Seidman MD, Gurgel RK, Lin SY, et al. Clinical Practice guideline: allergic rhinitis. Otolaryngol Neck Surg. 2015;152:S1–43. doi: 10.1177/0194599814561600
   PubMed Web of Science ®Google Scholar
• Prenner BM. A review of the clinical efficacy and safety of MP-AZEFLU, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US. J Asthma Allergy. 2016;9:135–143.
   PubMed Web of Science ®Google Scholar
• Deeks JJ, Higgins JPT, Altman DG editors. Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane. 2022. www.training.cochrane.org/handbook
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLOS Med. 2009;6(7):6. doi: 10.1371/journal.pmed.1000097
   Web of Science ®Google Scholar
• Bousquet J, Zuberbier T, Canonica GW, et al. Randomized controlled trial of desloratadine for persistent allergic rhinitis: Correlations between symptom improvement and quality of life. Allergy Asthma Proc. 2013;34(3):274–282. doi: 10.2500/aap.2013.34.3668
   PubMed Web of Science ®Google Scholar
• Rogkakou A, Villa E, Garelli V, et al. Persistent allergic rhinitis and the XPERT study. World Allergy Organ J. 2011;4:32–36. doi: 10.1186/1939-4551-4-S3-S32
   Google Scholar
• Holmberg K, Tonnel AB, Devillier P, et al. Desloratadine relieves nasal congestion and improves quality-of-life in persistent allergic rhinitis. Allergy. 2009 Nov;64(11):1663–1670.
   PubMed Web of Science ®Google Scholar
• Stübner P, Zieglmayer R, Horak F. A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit – the Vienna Challenge Chamber (VCC). Curr Med Res Opin. 2004;20(6):891–902. doi: 10.1185/030079904125003700
   PubMed Web of Science ®Google Scholar
• Okubo K, Ichimura M, Koyama T, et al. Double-blind placebo-controlled study of bepotastine besilate in pediatric patients with perennial allergic rhinitis. Expert Opin Pharmacother. 2015;16:2395–2408. doi: 10.1517/14656566.2015.1085511
   PubMedGoogle Scholar
• Potter PC. Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites. Allergy. 2003 Sep;58(9):893–899. doi:10.1034/j.1398-9995.2003.00171.x
   PubMed Web of Science ®Google Scholar
• Berger WE, Nayak A, Lanier BQ, et al. Efficacy and safety of once-daily ciclesonide nasal spray in children with allergic rhinitis. Pediatr Asthma, Allergy Immunol. 2008;21(2):73–82. doi: 10.1089/pai.2007.0022.73
   Google Scholar
• Berger WE, Jacobs RL, Amar NJ, et al. Efficacy and safety of beclomethasone dipropionate nasal aerosol in children with perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2015;115(2):130–136. doi: 10.1016/j.anai.2015.05.012
   PubMed Web of Science ®Google Scholar
• Chervinsky P, Kunjibettu S, Miller DL, et al. Long-term safety and efficacy of intranasal ciclesonide in adult and adolescent patients with perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2007;99:69–76. doi: 10.1016/S1081-1206(10)60624-2
   PubMed Web of Science ®Google Scholar
• Kim K, Weiswasser M, Nave R, et al. Safety of once-daily ciclesonide nasal spray in children 2 to 5 years of age with perennial allergic rhinitis. Pediatr Asthma, Allergy Immunol. 2007;20(4):229–242. doi: 10.1089/pai.2007.002
   Google Scholar
• Given JT, Cheema AS, Dreykluft T, et al. Fluticasone furoate nasal spray is effective and well tolerated for perennial allergic rhinitis in adolescents and adults. Am J Rhinol Allergy. 2010;24:444–450. doi: 10.2500/ajra.2010.24.3534
   PubMed Web of Science ®Google Scholar
• Okamoto Y, Fujieda S, Okano M, et al. House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis. Allergy: Eur J Allergy Clin Immunol. 2017;72(3):435–443. doi: 10.1111/all.12996
   Google Scholar
• Roux M, Devillier P, Yang WH, et al. Efficacy and safety of sublingual tablets of house dust mite allergen extracts: Results of a dose-ranging study in an environmental exposure chamber. J Allergy Clin Immunol. 2016;138(2):451–458.e5. doi: 10.1016/j.jaci.2016.03.039
   PubMed Web of Science ®Google Scholar
• Bachert C, Bousquet J, Canonica GW, et al. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol. 2004;114:838–844. doi: 10.1016/j.jaci.2004.05.070
   PubMed Web of Science ®Google Scholar
• Didier A, Malling HJ, Worm M, et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5–grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol. 2007;120(6):1338–1345. doi: 10.1016/j.jaci.2007.07.046
   PubMed Web of Science ®Google Scholar
• Carr W, Bernstein J, Lieberman P, et al. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. J Allergy Clin Immunol. 2012;129(5):1282–1289.e10. doi: 10.1016/j.jaci.2012.01.077
   PubMed Web of Science ®Google Scholar
• Segall N, Gawchik S, Georges G, et al. Efficacy and safety of levocetirizine in improving symptoms and health-related quality of life in US adults with seasonal allergic rhinitis: a randomized, placebo-controlled study. Ann Allergy Asthma Immunol. 2010;104:259–267. doi: 10.1016/j.anai.2009.12.003
   PubMed Web of Science ®Google Scholar
• Horak F, Zieglmayer PU, Zieglmayer R, et al. Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration. Br J Clin Pharmacol. 2005;60(1):24–31. doi: 10.1111/j.1365-2125.2005.02377.x
   PubMed Web of Science ®Google Scholar
• Nayak AS, Berger WE, Laforce CF, et al. Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitis. Allergy Asthma Proc. 2017;38(3):222–230. doi: 10.2500/aap.2017.38.4050
   PubMed Web of Science ®Google Scholar
• Raphael GD, Berger WE, Prenner BM, et al. Efficacy, safety, and optimal dose selection of beclomethasone dipropionate nasal aerosol for seasonal allergic rhinitis in adolescents and adults. Curr Med Res Opin. 2013;29(10):1329–1340. doi: 10.1185/03007995.2013.821055
   PubMed Web of Science ®Google Scholar
• Didier A, Worm M, Horak F, et al. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen–induced rhinoconjunctivitis. J Allergy Clin Immunol. 2011;128(3):559–566. doi: 10.1016/j.jaci.2011.06.022
   PubMed Web of Science ®Google Scholar
• Didier A, Melac M, Montagut A, et al. Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy. Allergy: Eur J Allergy Clin Immunol. 2009;64(1):166–171. doi: 10.1111/j.1398-9995.2008.01767.x
   Google Scholar
• Svensson C, Andersson M, Greiff L, et al. Effects of topical budesonide and levocabastine on nasal symptoms and plasma exudation responses in seasonal allergic rhinitis. Allergy: Eur J Allergy Clin Immunol. 1998;53(4):367–374. doi: 10.1111/j.1398-9995.1998.tb03907.x
   Google Scholar
• Pfaar O, Van Twuijver E, Boot JD, et al. A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: Results of a phase II study. Allergy: Eur J Allergy Clin Immunol. 2016;71(1):99–107. doi: 10.1111/all.12760
   Google Scholar
• Worm M, Rak S, Samoliński B, et al. Efficacy and safety of birch pollen allergoid subcutaneous immunotherapy: A 2-year double-blind, placebo-controlled, randomized trial plus 1-year open-label extension. Clin Exp Allergy. 2019;49(4):516–525. doi: 10.1111/cea.13331
   PubMed Web of Science ®Google Scholar
• Schäfer T, Schnoor M, Wagenmann M, et al. Therapeutic index (TIX) for intranasal corticosteroids in the treatment of allergic rhinitis. Rhinology. 2011;49(3):272–280. doi: 10.4193/Rhino10.170
   PubMed Web of Science ®Google Scholar
• Bousquet J, Schünemann HJ, Togias A, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020;145(1):70–80.e3. doi: 10.1016/j.jaci.2019.06.049
   PubMed Web of Science ®Google Scholar
• Richardson M, Garner P, Donegan S. Interpretation of subgroup analyses in systematic reviews: A tutorial. Clin Epidemiol Glob Heal. 2019;7(2):192–198. doi: 10.1016/j.cegh.2018.05.005
   Web of Science ®Google Scholar
• Cuijpers P, Griffin JW, Furukawa TA. The lack of statistical power of subgroup analyses in meta-analyses: A cautionary note. Epidemiol Psychiatr Sci. 2021;30:2012–2014. doi: 10.1017/S2045796021000664
   Web of Science ®Google Scholar
• Jager KJ, Zoccali C, MacLeod A, et al. Confounding: What it is and how to deal with it. Kidney Int. 2008;73:256–260. doi: 10.1038/sj.ki.5002650
   PubMed Web of Science ®Google Scholar
• Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777–784. doi: 10.7326/M14-2385
   PubMed Web of Science ®Google Scholar